We are hiring!! Fully funded a PhD position (salary+reagents) is available in our group! If you are interested, please check this out: https://t.co/FYbATV5bUb. The call will be closed on Sep 24th.
We are recruiting! Looking for a PhD student to start on January 2025 within the ImmuDocs doctoral program, in the beautiful Turku. You get to work with awesome people in an awesome project 🔥Involves wet lab, high-end microscopy, and computational analysis /proteomics🎇
And here is the next one. A great effort from many people and @FaronPharm Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial: Cell Reports Medicine https://t.co/LAYFss8fJI
Thrilled to share our research at #IUIS2023 in beautiful South Africa! 🇿🇦🌍
Grateful for the enriching remarks and collaboration opportunities.
All thanks to @FinnSocImm for the grant support and of course to @UniTurku and @InFLAMES_Health for being my scientific harbor.
Grateful for the valuable 1-month experience as an assistant in the Head & Neck Surgery department at Turku University Hospital, Finland! Impressed by the skills of the doctors and nurses! Thankful for being a part of life-changing operations and the opportunity to learn. 😊
InFLAMES PI Alexander Mildner is named Highly Cited Researcher 2023! The list by @Clarivate ranks scholars whose articles other researchers have cited the most over the last decade. Congratulations Alex🔥!
https://t.co/4t5HS6tInh
@MildnerLab @UniTurku@AboAkademi@SuomenAkatemia
Our Director, Academician Sirpa Jalkanen welcomes all registered participants to InFLAMES Corporate Corner at October 6th. The event is fully booked but you can register for the waiting list here https://t.co/CMsSCU0Yxc.
@UniTurku@AboAkademi@SuomenAkatemia@healthcampustku
Mistä solut tietävät, minne niiden pitää mennä? Puolustussolut seuraavat elimistön kemiallisia vihjeitä, mutta eivät ole vain niiden varassa, kertoo InFLAMES-tutkija @jonna_alanko.
#immunologia@aboakademi@SuomenAkatemia@Sixt_Lab@MedicityL
https://t.co/GTuAJ2qQB3
Immune cells do not just passively follow chemical cues in their environment. According to InFLAMES researcher @jonna_alanko, they can also shape these cues and navigate in self-organised manner. #immunology@aboakademi@SuomenAkatemia@Sixt_Lab@MedicityL https://t.co/dyoEKlgYB0
Back in the office after ammmaziiiinngg 4 days at Lofoten, Norway, taking part in the 4th Immunology Workshop organized by amazing @anspurk and the team! Every day great science, full sunshine and simply spectacular views 🤯🌞💥⛰️ Thank you so much for inviting me ❤️
Finally, the day has come for the long-awaited Finnish-Japanese Immunology Symposium! @akirataked brilliantly presented the group's immunological projects 🧪 Huge thanks to co-organizer Riitta Lahesmaa @LahesmaaGroup for making this event a huge success 🇯🇵🇫🇮
@InFLAMES_Health
Nice to see photos of the Montpellier Node! To learn more about the technologies & expertise 🔬available in #openaccess, click here⤵️
https://t.co/Kyzqp9TGY1
🚨Check out our second Turku BioImaging (TBI) Newsletter:
https://t.co/egxzvABP9C
Highlights:
▶️Pix4Business - TBI´s business cooperation project
▶️Calls and Funding 2023
▶️TBI and Euro-BioImaging activities
▶️Ocul-AR mobile app
▶️Upcoming events
Have a wonderful summer🌅
Coming up: Finnish-Japanese #immunology symposium August 29th-30th at Mauno Koivisto Centre,Turku. The theme of the symposium is Emerging concepts in immunology – from basic mechanisms to treating immune mediated diseases
Register at https://t.co/E2xPdrBHWO
@BioscienceTurku
HUS Syöpäkeskuksedda tehtiin ensimmäistä kertaa rintasyöpäpotilaalle kohdennettu imusolmukepoisto, jossa poistettiin vain potilaan imusolmuke, johon syöpä oli levinnyt. Tapa otetaan laajempaan käyttöön syksyllä ja se vähentää pitkäaikaishaittoja. Upeaa!
https://t.co/mn4nP8FCIM
The group members Xin Wang, @qi_dawei and Jinghui Yang are presenting their posters today to show cancer cell recognition (t191), folding single chain polymer (t122) and DCC regulated by cell responsiveness(t26). Waiting for discussion @ISMSC2023